In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

SECTION 1. PHYSICAL EDUCATION FOR PROGRESS.

Title X of the Elementary and Secondary Education Act of 1965 (20
U.S.C. 8001 et seq.) is amended by adding at the end the following:

''PART L--PHYSICAL EDUCATION FOR PROGRESS

''SEC. 10999A. SHORT TITLE.

''This part may be cited as the 'Physical Education for Progress
Act'.

''SEC. 10999B. PURPOSE.

''The purpose of this part is to award grants and contracts to
local educational agencies to enable the local educational agencies to
initiate, expand, and improve physical education programs for all
kindergarten through 12th grade students.

''SEC. 10999C. FINDINGS.

''Congress makes the following findings:
''(1) Physical education is essential to the development of
growing children.
''(2) Physical education helps improve the overall health
of children by improving their cardiovascular endurance,
muscular strength and power, and flexibility, and by enhancing
weight regulation, bone development, posture, skillful moving,
active lifestyle habits, and constructive use of leisure time.
''(3) Physical education helps improve the self esteem,
interpersonal relationships, responsible behavior, and
independence of children.
''(4) Children who participate in high quality daily
physical education programs tend to be more healthy and
physically fit.
''(5) The percentage of young people who are overweight has
more than doubled in the 30 years preceding 1999.
''(6) Low levels of activity contribute to the high
prevalence of obesity among children in the United States.
''(7) Obesity related diseases cost the United States
economy more than $100,000,000,000 every year.
''(8) Inactivity and poor diet cause at least 300,000
deaths a year in the United States.
''(9) Physically fit adults have significantly reduced risk
factors for heart attacks and stroke.
''(10) Children are not as active as they should be and
fewer than 1 in 4 children get 20 minutes of vigorous activity
every day of the week.
''(11) The Surgeon General's 1996 Report on Physical
Activity and Health, and the Centers for Disease Control and
Prevention, recommend daily physical education for all students
in kindergarten through grade 12.
''(12) Twelve years after Congress passed House Concurrent
Resolution 97, 100th Congress, agreed to December 11, 1987,
encouraging State and local governments and local educational
agencies to provide high quality daily physical education
programs for all children in kindergarten through grade 12,
little progress has been made.
''(13) Every student in our Nation's schools, from
kindergarten through grade 12, should have the opportunity to
participate in quality physical education. It is the unique
role of quality physical education programs to develop the
health-related fitness, physical competence, and cognitive
understanding about physical activity for all students so that
the students can adopt healthy and physically active
lifestyles.
''(14) Every student in our Nation's schools should have
the opportunity to achieve the goals established by Healthy
People 2000 and Healthy People 2010.

''SEC. 10999D. PROGRAM AUTHORIZED.

''The Secretary is authorized to award grants to, and enter into
contracts with, local educational agencies to pay the Federal share of
the costs of initiating, expanding, and improving physical education
programs for kindergarten through grade 12 students by--
''(1) providing equipment and support to enable students to
actively participate in physical education activities;
''(2) developing or enhancing physical education curricula
to meet national goals for physical education developed by the
Secretary in consultation with the National Association for
Sport and Physical Education; and
''(3) providing funds for staff and teacher training and
education.

''SEC. 10999E. APPLICATIONS; PROGRAM REQUIREMENTS.

''(a) Applications.--Each local educational agency desiring a grant
or contract under this part shall submit to the Secretary an
application that contains a plan to initiate, expand, or improve
physical education programs in the schools served by the agency in
order to make progress toward meeting--
''(1) the goals described in subsection (b); or
''(2) State standards for physical education.
''(b) Goals.--The goals referred to in subsection (a) are as
follows:
''(1) Physical education programs shall facilitate
achievement of the national goals for physical education
described in section 10999D(2), and the curriculum of the
programs may provide--
''(A) fitness education and assessment to help
children understand, improve, or maintain their
physical well-being;
''(B) instruction in a variety of motor skills and
physical activities designed to enhance the physical,
mental, and social or emotional development of every
child;
''(C) development of cognitive concepts about motor
skill and physical fitness that support a lifelong
healthy lifestyle;
''(D) opportunities to develop positive social and
cooperative skills through physical activity
participation; and
''(E) instruction in healthy eating habits and good
nutrition.
''(2) Teachers of physical education shall be afforded the
opportunity for professional development to stay abreast of the
latest research, issues, and trends in the field of physical
education.
''(c) Special Rule.--For the purpose of this part, extracurricular
activities such as team sports and Reserve Officers' Training Corps
(ROTC) program activities shall not be considered as part of the
curriculum of a physical education program assisted under this part.

''SEC. 10999F. PROPORTIONALITY.

''The Secretary shall ensure that grants awarded and contracts
entered into under this part shall be equitably distributed between
local educational agencies serving urban and rural areas, and between
local educational agencies serving large and small numbers of students.

''SEC. 10999G. PRIVATE SCHOOL STUDENTS AND HOME-SCHOOLED STUDENTS.

''An application for funds under this part, consistent with the
number of home-schooled children or children enrolled in private
elementary schools, middle schools, and secondary schools located in
the school district of a local educational agency, may provide for the
participation of such children and their teachers in the activities
assisted under this part.

''SEC. 10999H. REPORT REQUIRED FOR CONTINUED FUNDING.

''As a condition to continue to receive grant or contract funding
after the first year of a multiyear grant or contract under this part,
the administrator of the grant or contract for the local educational
agency shall submit to the Secretary an annual report that describes
the activities conducted during the preceding year and demonstrates
that progress has been made toward achieving goals described in section
10999E(b) or meeting State standards for physical education.

''SEC. 10999I. REPORT TO CONGRESS.

''The Secretary shall submit a report to Congress not later than
June 1, 2003, that describes the programs assisted under this part,
documents the success of such programs in improving physical fitness,
and makes such recommendations as the Secretary determines appropriate
for the continuation and improvement of the programs assisted under
this part.

''SEC. 10999J. ADMINISTRATIVE COSTS.

''Not more than 5 percent of the grant or contract funds made
available to a local educational agency under this part for any fiscal
year may be used for administrative costs.

''SEC. 10999K. FEDERAL SHARE; SUPPLEMENT NOT SUPPLANT.

''(a) Federal Share.--The Federal share under this part may not
exceed--
''(1) 90 percent of the total cost of a project for the
first year for which the project receives assistance under this
part; and
''(2) 75 percent of such cost for the second and each
subsequent such year.
''(b) Supplement not Supplant.--Funds made available under this
part shall be used to supplement and not supplant other Federal, State,
and local funds available for physical education activities.

''SEC. 10999L. AUTHORIZATION OF APPROPRIATIONS.

''There are authorized to be appropriated $30,000,000 for fiscal
year 2000, $70,000,000 for fiscal year 2001, and $100,000,000 for each
of the fiscal years 2002 through 2004, to carry out this part. Such
funds shall remain available until expended.''.
Requires such grants and contracts to be used for: (1) providing equipment and support to enable students to actively participate in physical education activities; (2) developing or enhancing physical education curricula to meet national goals developed by the Secretary; and (3) providing funds for staff and teacher training and education.
Requires LEA assistance applications for such assistance to contain plans for helping school physical education programs make progress toward meeting State standards for physical education or specified goals. Prohibits extracurricular activities such as team sports and Reserve Officers' Training Corps (ROTC) program activities from consideration as part of the curriculum of a physical education program assisted under this Act.
Authorizes appropriations.

SECTION 1. SHORT TITLE.

This Act may be cited as the ''Drug Competition Act of 2002''.

SEC. 2. FINDINGS.

Congress finds that--
(1) prescription drug prices are increasing at an alarming
rate and are a major worry of many senior citizens and American
families;
(2) there is a potential for companies with patent rights
regarding brand name drugs and companies which could
manufacture generic versions of such drugs to enter into
financial deals that could tend to restrain trade and greatly
reduce competition and increase prescription drug expenditures
for American citizens; and
(3) enhancing competition among these companies can
significantly reduce prescription drug expenditures for
Americans.

SEC. 3. PURPOSES.

The purposes of this Act are--
(1) to provide timely notice to the Department of Justice
and the Federal Trade Commission regarding agreements between
companies with patent rights regarding brand name drugs and
companies which could manufacture generic versions of such
drugs; and
(2) by providing timely notice, to enhance the
effectiveness and efficiency of the enforcement of the
antitrust and competition laws of the United States.

SEC. 4. DEFINITIONS.

In this Act:
(1) ANDA.--The term ''ANDA'' means an Abbreviated New Drug
Application, as defined under section 201(aa) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 321(aa)).
(2) Assistant attorney general.--The term ''Assistant
Attorney General'' means the Assistant Attorney General in
charge of the Antitrust Division of the Department of Justice.
(3) Brand name drug.--The term ''brand name drug'' means a
drug approved under section 505(c) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 355(c)).
(4) Brand name drug company.--The term ''brand name drug
company'' means the party that received Food and Drug
Administration approval to market a brand name drug pursuant to
an NDA, where that drug is the subject of an ANDA, or a party
owning or controlling enforcement of any patent listed in the
Approved Drug Products With Therapeutic Equivalence Evaluations
of the Food and Drug Administration for that drug, under
section 505(b) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 355(b)).
(5) Commission.--The term ''Commission'' means the Federal
Trade Commission.
(6) Generic drug.--The term ''generic drug'' means a
product that the Food and Drug Administration has approved
under section 505(j) of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 355(j)).
(7) Generic drug applicant.--The term ''generic drug
applicant'' means a person who has filed or received approval
for an ANDA under section 505(j) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 355(j)).
(8) NDA.--The term ''NDA'' means a New Drug Application, as
defined under section 505(b) et seq. of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 355(b) et seq.)

SEC. 5. NOTIFICATION OF AGREEMENTS.

(a) In General.--
(1) Requirement.--A generic drug applicant that has
submitted an ANDA containing a certification under section
505(j)(2)(vii)(IV) of the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 355(j)(2)(vii)(IV)) and a brand name drug company
that enter into an agreement described in paragraph (2), prior
to the generic drug that is the subject of the application
entering the market, shall each file the agreement as required
by subsection (b).
(2) Definition.--An agreement described in this paragraph
is an agreement regarding--
(A) the manufacture, marketing or sale of the brand
name drug that is the subject of the generic drug
applicant's ANDA;
(B) the manufacture, marketing or sale of the
generic drug that is the subject of the generic drug
applicant's ANDA; or
(C) the 180-day period referred to in section
505(j)(5)(B)(iv) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 355(j)(5)(B)(iv)) as it applies
to such ANDA or to any other ANDA based on the same
brand name drug.
(b) Filing.--
(1) Agreement.--The generic drug applicant and the brand
name drug company entering into an agreement described in
subsection (a)(2) shall file with the Assistant Attorney
General and the Commission the text of any such agreement,
except that the generic drug applicant and the brand-name drug
company shall not be required to file an agreement that solely
concerns--
(A) purchase orders for raw material supplies;
(B) equipment and facility contracts;
(C) employment or consulting contracts; or
(D) packaging and labeling contracts.
(2) Other agreements.--The generic drug applicant and the
brand name drug company entering into an agreement described in
subsection (a)(2) shall file with the Assistant Attorney
General and the Commission the text of any other agreements not
described in subsection (a)(2) between the generic drug
applicant and the brand name drug company which are contingent
upon, provide a contingent condition for, or are otherwise
related to an agreement which must be filed under this Act.
(3) Description.--In the event that any agreement required
to be filed by paragraph (1) or (2) has not been reduced to
text, both the generic drug applicant and the brand name drug
company shall file written descriptions of the non-textual
agreement or agreements that must be filed sufficient to reveal
all of the terms of the agreement or agreements.

SEC. 6. FILING DEADLINES.

Any filing required under section 5 shall be filed with the
Assistant Attorney General and the Commission not later than 10
business days after the date the agreements are executed.

SEC. 7. DISCLOSURE EXEMPTION.

Any information or documentary material filed with the Assistant
Attorney General or the Commission pursuant to this Act shall be exempt
from disclosure under section 552 of title 5, and no such information
or documentary material may be made public, except as may be relevant
to any administrative or judicial action or proceeding. Nothing in this
section is intended to prevent disclosure to either body of Congress or
to any duly authorized committee or subcommittee of the Congress.

SEC. 8. ENFORCEMENT.

(a) Civil Penalty.--Any brand name drug company or generic drug
applicant which fails to comply with any provision of this Act shall be
liable for a civil penalty of not more than $11,000, for each day
during which such entity is in violation of this Act. Such penalty may
be recovered in a civil action brought by the United States, or brought
by the Commission in accordance with the procedures established in
section 16(a)(1) of the Federal Trade Commission Act (15 U.S.C. 56(a)).
(b) Compliance and Equitable Relief.--If any brand name drug
company or generic drug applicant fails to comply with any provision of
this Act, the United States district court may order compliance, and
may grant such other equitable relief as the court in its discretion
determines necessary or appropriate, upon application of the Assistant
Attorney General or the Commission.

SEC. 9. RULEMAKING.

The Commission, with the concurrence of the Assistant Attorney
General and by rule in accordance with section 553 of title 5 United
States Code, consistent with the purposes of this Act--
(1) may define the terms used in this Act;
(2) may exempt classes of persons or agreements from the
requirements of this Act; and
(3) may prescribe such other rules as may be necessary and
appropriate to carry out the purposes of this Act.

SEC. 10. SAVINGS CLAUSE.

Any action taken by the Assistant Attorney General or the
Commission, or any failure of the Assistant Attorney General or the
Commission to take action, under this Act shall not bar any proceeding
or any action with respect to any agreement between a brand name drug
company and a generic drug applicant at any time under any other
provision of law, nor shall any filing under this Act constitute or
create a presumption of any violation of any antitrust or competition
laws.

SEC. 11. EFFECTIVE DATE.

This Act shall--
(1) take effect 30 days after the date of enactment of this
Act; and
(2) shall apply to agreements described in section 5 that
are entered into 30 days after the date of enactment of this
Act.

Passed the Senate November 18, 2002.

Attest:

JERI THOMSON,

Secretary.
Drug Competition Act of 2002 - (Sec. 5) Requires a generic drug applicant that has submitted an Abbreviated New Drug Application (ANDA) and a brand name drug company that enter into an agreement, prior to the generic drug entering the market, regarding the manufacture, marketing, or sale of the brand name or the generic drug, or regarding the 180-day semi-exclusivity period referred to in the Federal Food, Drug, and Cosmetic Act as it applies to such ANDA or any other ANDA based on the same brand name drug, to each file such agreement and any related agreements with the Assistant Attorney General and the Federal Trade Commission (FTC). Makes an exception for agreements that solely concern purchase orders for raw material supplies, equipment and facility contracts, or employment or consulting contracts. Requires such agreements to be filed not later than ten business days after the date they are executed.(Sec. 7) Exempts any such information or documentary material filed from disclosure under the Freedom of Information Act. Prohibits such information or material from being made public, except as relevant to any administrative or judicial action or proceeding.(Sec. 8) Subjects an applicant or company to a civil penalty of up to $11,000 for each day such entity fails to comply with this Act, recoverable in a civil action brought by the United States or the FTC. Authorizes a U.S. district court to order compliance and grant equitable relief.

SECTION 1. FINDINGS.

Congress makes the following findings:
(1) The military health care system of the Department of
Defense and the Veterans Health Administration of the
Department of Veterans Affairs are national institutions that
collectively manage more than 1,500 hospitals, clinics, and
health care facilities worldwide to provide services to more
than 11,000,000 beneficiaries.
(2) In the post-Cold War era, these institutions are in a
profound transition that involves challenging opportunities.
(3) During the period from 1988 to 1998, the number of
military medical personnel has declined by 15 percent and the
number of military hospitals has been reduced by one-third.
(4) During the two years since 1996, the Department of
Veterans Affairs has revitalized its structure by
decentralizing authority into 22 Veterans Integrated Service
Networks.
(5) In the face of increasing costs of medical care,
increased demands for health care services, and increasing
budgetary constraints, the Department of Defense and the
Department of Veterans Affairs have embarked on a variety of
dynamic and innovative cooperative programs ranging from shared
services to joint venture operations of medical facilities.
(6) In 1984, there was a combined total of 102 Department
of Veterans Affairs and Department of Defense facilities with
sharing agreements. By 1997, that number had grown to 420.
During the six years from fiscal year 1992 through fiscal year
1997, shared services increased from slightly over 3,000
services to more than 6,000 services ranging from major medical
and surgical services, laundry, blood, and laboratory services
to unusual speciality care services.
(7) The Department of Defense and the Department of
Veterans Affairs are conducting four health care joint ventures
in New Mexico, Nevada, Texas, Oklahoma, and are planning to
conduct four more such ventures in Alaska, Florida, Hawaii, and
California.

SEC. 2. SENSE OF CONGRESS.

It is the sense of Congress that--
(1) the Department of Defense and the Department of
Veterans Affairs are to be commended for the cooperation
between the two departments in the delivery of medical care, of
which the cooperation involved in the establishment and
operation of the Department of Defense and the Department of
Veterans Affairs Executive Council is a praiseworthy example;
(2) the two departments are encouraged to continue to
explore new opportunities to enhance the availability and
delivery of medical care to beneficiaries by further enhancing
the cooperative efforts of the departments; and
(3) enhanced cooperation is encouraged for--
(A) the general areas of access to quality medical
care, identification and elimination of impediments to
enhanced cooperation, and joint research and program
development; and
(B) the specific areas in which there is
significant potential to achieve progress in
cooperation in a short term, including computerization
of patient records systems, participation of the
Department of Veterans Affairs in the TRICARE program,
pharmaceutical programs, and joint physical
examinations.

SEC. 3. JOINT SURVEY ON POPULATIONS SERVED.

(a) Survey Required.--The Secretary of Defense and the Secretary of
Veterans Affairs shall jointly conduct a survey of their respective
medical care beneficiary populations to identify, by category of
beneficiary (defined as the Secretaries consider appropriate), the
expectations of, requirements for, and behavior patterns of the
beneficiaries with respect to medical care. The two Secretaries shall
develop the protocol for the survey jointly, but shall obtain the
services of an entity independent of the Department of Defense and the
Department of Veterans Affairs for carrying out the survey.
(b) Matters To Be Surveyed.--The survey shall include the
following:
(1) Demographic characteristics, economic characteristics,
and geographic location of beneficiary populations with regard
to catchment or service areas.
(2) The types and frequency of care required by veterans,
retirees, and dependents within catchment or service areas of
Department of Defense and Veterans Affairs medical facilities
and outside those areas.
(3) The numbers of, characteristics of, and types of
medical care needed by the veterans, retirees, and dependents
who, though eligible for medical care in Department of Defense
or Department of Veterans Affairs treatment facilities or other
federally funded medical programs, choose not to seek medical
care from those facilities or under those programs, and the
reasons for that choice.
(4) The obstacles or disincentives for seeking medical care
from such facilities or under such programs that veterans,
retirees, and dependents perceive.
(5) Any other matters that the Secretary of Defense and the
Secretary of Veterans Affairs consider appropriate for the
survey.
(c) Report.--The Secretary of Defense and the Secretary of Veterans
Affairs shall submit a report on the results of the survey to the
appropriate committees of Congress. The report shall contain the
matters described in subsection (b) and any proposals for legislation
that the Secretaries recommend for enhancing Department of Defense and
Department of Veterans Affairs cooperative efforts with respect to the
delivery of medical care.

SEC. 4. REVIEW OF IMPEDIMENTS TO COOPERATION.

(a) Review Required.--The Secretary of Defense and the Secretary of
Veterans Affairs shall jointly conduct a review to identify impediments
to cooperation between the Department of Defense and the Department of
Veterans Affairs regarding the delivery of medical care. The matters
reviewed shall include the following:
(1) All laws, policies, and regulations, and any attitudes
of beneficiaries of the health care systems of the two
departments, that have the effect of preventing the
establishment, or limiting the effectiveness, of cooperative
health care programs of the departments.
(2) The requirements and practices involved in the
credentialling and licensure of health care providers.
(3) The perceptions of beneficiaries in a variety of
categories (defined as the Secretaries consider appropriate)
regarding the various Federal health care systems available for
their use.
(b) Report.--The Secretaries shall jointly submit a report on the
results of the review to the appropriate committees of Congress. The
report shall include any proposals for legislation that the Secretaries
recommend for eliminating or reducing impediments to interdepartmental
cooperation that are identified during the review.

SEC. 5. PARTICIPATION OF DEPARTMENT OF VETERANS AFFAIRS IN TRICARE.

(a) Review Required.--The Secretary of Defense shall review the
TRICARE program to identify opportunities for increased participation
by the Department of Veterans Affairs in that program. The ongoing
collaboration between Department of Defense officials and Department of
Veterans Affairs officials regarding increasing the participation shall
be included among the matters reviewed.
(b) Semiannual Report.--The Secretary of Defense and the Secretary
of Veterans Affairs shall jointly submit to the appropriate committees
of Congress a semiannual report on the status of the review and on
efforts to increase the participation of the Department of Veterans
Affairs in the TRICARE program. No report is required under this
subsection after the submission of a semiannual report in which the
Secretaries declare that the Department of Veterans Affairs is
participating in the TRICARE program to the extent that can reasonably
be expected to be attained.

SEC. 6. PHARMACEUTICAL BENEFITS AND PROGRAMS.

(a) Examination Required.--(1) The Federal Pharmaceutical Steering
Committee shall--
(A) undertake a comprehensive examination of existing
pharmaceutical benefits and programs for beneficiaries of
Federal medical care programs, including matters relating to
the purchasing, distribution, and dispensing of pharmaceuticals
and the management of mail order pharmaceuticals programs; and
(B) review the existing methods for contracting for and
distributing medical supplies and services.
(2) The committee shall submit a report on the results of the
examination to the appropriate committees of Congress.
(b) Report.--The committee shall submit a report on the results of
the examination to the appropriate committees of Congress.

SEC. 7. STANDARDIZATION OF PHYSICAL EXAMINATIONS FOR DISABILITIES.

The Secretary of Defense and the Secretary of Veterans Affairs
shall submit to the appropriate committees of Congress a report on the
status of the efforts of the Department of Defense and the Department
of Veterans Affairs to standardize physical examinations administered
by the two departments for the purpose of determining or rating
disabilities.

SEC. 8. APPROPRIATE COMMITTEES OF CONGRESS DEFINED.

For the purposes of this Act, the appropriate committees of
Congress are as follows:
(1) The Committee on Armed Services and the Committee on
Veterans' Affairs of the Senate.
(2) The Committee on National Security and the Committee on
Veterans' Affairs of the House of Representatives.

SEC. 9. DEADLINES FOR SUBMISSION OF REPORTS.

(a) Report on Joint Survey of Populations Served.--The report
required by section 3(c) shall be submitted not later than January 1,
2000.
(b) Report on Review of Impediments to Cooperation.--The report
required by section 4(b) shall be submitted not later than May 1, 1999.
(c) Semiannual Report on Participation of Department of Veterans
Affairs in TRICARE.--The semiannual report required by section 5(b)
shall be submitted not later than January 1 and June 1 of each year.
(d) Report on Examination of Pharmaceutical Benefits and
Programs.--The report on the examination required under section 6 shall
be submitted not later than 60 days after the completion of the
examination.
(e) Report on Standardization of Physical Examinations for
Disabilities.--The report required by section 7 shall be submitted not
later than June 1, 1999.
Expresses the sense of the Congress that: (1) the Department of Defense (DOD) and the Department of Veterans Affairs (VA) should be commended for their cooperative efforts in the delivery of medical care; (2) DOD and VA should continue to explore new opportunities to enhance the availability and delivery of medical care to beneficiaries by further enhancing such cooperative efforts; and (3) such enhanced cooperation is encouraged for the general areas of access to quality medical care, identification and elimination of impediments to cooperation, and joint research and program development and for the specific areas in which there is significant potential to achieve progress in cooperation in a short term, including computerization of patient records systems, VA participation in TRICARE, pharmaceutical programs, and joint physical examinations.
Directs the DOD and VA Secretaries to jointly conduct: (1) a survey of their respective medical care beneficiary populations to identify the expectations of, requirements for, and behavior patterns of such beneficiaries with respect to medical care; and (2) a review of impediments to cooperation in the delivery of medical care. Requires reports to the congressional defense and veterans' affairs committees (the committees).
Requires the Secretary of Defense to review and report semiannually to the committees on opportunities for increased VA participation in TRICARE.
Directs the Federal Pharmaceutical Steering Committee to: (1) undertake a comprehensive examination of existing pharmaceutical benefits and programs for beneficiaries of Federal medical care programs; (2) review the existing methods for contracting for and distributing medical supplies and services; and (3) report examination results to the committees.
Directs the Secretaries to submit to the committees a report on the status of DOD and VA efforts to standardize physical examinations administered to determine or rate disabilities.
Provides deadlines for required reports.